Guninaa Pharmaceuticals Private Limited

Guninaa Pharmaceuticals Private Limited - pharma in Bareilly, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U47721UP2023PTC181171 Incorporated 29 April 2023 ROC Kanpur HQ Bareilly, Uttar Pradesh, India
Active Private Limited Company pharma
Revenue · FY 2026
₹46.01 Cr
▲ 47% YoY
Net loss · FY 2026
₹72.13 Lakh
Net margin -1.6%
EBITDA · FY 2026
₹51.55 Lakh
EBITDA margin 1.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹12 Cr
Secured borrowings
Company age
3 yrs
Est. 2023
Directors on board
3
As per MCA filings

About Guninaa Pharmaceuticals Private Limited

Data last updated:

Guninaa Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 April 2023.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U47721UP2023PTC181171.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Narasaiah Arigela and Yahna Khatwani.

Its last annual general meeting (AGM) was held on 07 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at C/O Mahendra Khatwani S/O Narendra Khatwani, R/O Mohalla Gali Nababan Bareilly Bara Bazaar Bareilly, Uttar Pradesh, India – 243001.

As per the financials filed for FY 2026, the company reported a revenue of ₹46.01 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net loss of ₹72.13 Lakh (net margin -1.6%) and EBITDA of ₹51.55 Lakh (EBITDA margin 1.1%).

As per MCA filings, the company has open charges of ₹12 Cr on record.

For more details, the company can be reached via its website guninaapharma.com.

Company details

CIN U47721UP2023PTC181171
Registration Number 181171
Incorporation Date 29 April 2023
ROC Kanpur
Listing Status Unlisted
Company Status Active

Contact details

Guninaa Pharmaceuticals Private Limited's registered office is in Bareilly, Uttar Pradesh.

  • Registered Address
    C/O Mahendra Khatwani S/O Narendra Khatwani, R/O Mohalla Gali Nababan Bareilly Bara Bazaar Bareilly, Uttar Pradesh, India – 243001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Guninaa Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Guninaa Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Guninaa Pharmaceuticals Private Limited, buy the company report.

Financials of Guninaa Pharmaceuticals Private Limited

FY 2026 filings available

Guninaa Pharmaceuticals Private Limited reported revenue of ₹46.01 Cr (up 47% YoY) for FY 2026.

Revenue · FY 2026
₹46.01 Cr ▲ 47%
Net loss · FY 2026
₹72.13 Lakh margin -1.6%
EBITDA · FY 2026
₹51.55 Lakh margin 1.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 47%
EBITDA CAGR growth
1 year
▲ 179%

Revenue rose 47% in the latest year. EBITDA rose 179% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations₹46.01 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹51.55 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹72.13 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24
Profitability
EBITDA Margin1.1%
Net Profit Margin-1.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Guninaa Pharmaceuticals Private Limited, buy the company report.

Board of directors of Guninaa Pharmaceuticals Private Limited

Guninaa Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Narasaiah ArigelaDirector05 Jul 20242 Years 4 MonthsCurrent
Yahna KhatwaniDirector29 Apr 20233 Years 6 MonthsCurrent
Mahendra KhatwaniDirector29 Apr 20233 Years 6 MonthsCurrent

Auditor

Guninaa Pharmaceuticals Private Limited is audited by R.N. ASSOCIATES Chartered Accountants for the financial year 2026.

Auditor firmFinancial yearFirm registration number
R.N. ASSOCIATES Chartered AccountantsFY 20260000181c

Shareholding

The shareholding of Guninaa Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Guninaa Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹12 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹12.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Jul 2024100957918Hdfc Bank Limited₹12 CrOpen

To see the full charge records of Guninaa Pharmaceuticals Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Guninaa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Guninaa Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Guninaa Pharmaceuticals Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Narasaiah Arigela ceased to be Additional Director on 24 Sep 2024.

Filing
Guninaa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Kanpur.
Charges
A charge with Hdfc Bank Limited of Rs. 1,200.00 Lakh registered on 24 Jul 2024 with Charge ID 100957918 was modified on 26 Sep 2025.
AGM
Guninaa Pharmaceuticals Private Limited last Annual general meeting of members was held on 07 Jul 2025 as per latest MCA records.
Ceased
Narasaiah Arigela ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,200.00 Lakh with Charge ID 100957918 was registered on 24 Jul 2024.
Appointed
Narasaiah Arigela was appointed as Director.
Appointed
Mahendra Khatwani was appointed as Director.
Appointed
Yahna Khatwani was appointed as Director.
Incorporation
29 Apr 2023
Guninaa Pharmaceuticals Private Limited was registered on 29 Apr 2023 with Roc Kanpur & aged 3 years 6 months as per MCA records.

Frequently asked questions

Guninaa Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 April 2023 (3+ years old) and is registered under CIN U47721UP2023PTC181171.

Guninaa Pharmaceuticals has 3 current directors:

The latest financial statements of Guninaa Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 07 July 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Guninaa Pharmaceuticals is U47721UP2023PTC181171. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Guninaa Pharmaceuticals was incorporated on 29 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.

Narasaiah Arigela ceased to be Additional Director on 24 Sep 2024. Narasaiah Arigela was appointed as Director on 05 Jul 2024. Mahendra Khatwani was appointed as Director on 29 Apr 2023. Guninaa Pharmaceuticals has 4 board changes on record in total.

Guninaa Pharmaceuticals can be reached through the website guninaapharma.com. Its registered office is in Bareilly, Uttar Pradesh, India.

The registered office of Guninaa Pharmaceuticals is at CO Mahendra Khatwani SO Narendra Khatwani, RO Mohalla Gali Nababan Bareilly Bara Bazaar Bareilly, Uttar Pradesh, India – 243001.

Guninaa Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Guninaa Pharmaceuticals has open charges of ₹12 Cr and no satisfied charges on record as per latest MCA filings.